Trial intelligence / Profile preview

Acute Qvar response as a predictor of 4-week Qvar response in childhood asthma

NL-OMON47635Phase 4Recruiting

Sponsor
Medisch Spectrum Twente
Start
Nov 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of beclomethasone in asthma, sponsored by Medisch Spectrum Twente. Started Nov 2016; status: recruiting.

02

Drugs

beclomethasone
03

Conditions

asthma

Beyond the preview

Go deeper on NL-OMON47635.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON47635.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call